Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Human Embryonic Stem Cell Therapy Advanced Cell Technology Inc. Stories

2009-06-11 15:39:26

Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for human clinical trials. Two important early potential hESC applications are the use of RPE for the treatment of age-related macular degeneration and Stargardt disease, an untreatable form of eye disease that leads to early-onset blindness. The...